XML 86 R74.htm IDEA: XBRL DOCUMENT v3.25.2
Financial Risk Management Objectives and Policies (Tables)
12 Months Ended
Jun. 30, 2025
Interest rate risk [member]  
Disclosure Of Risk Management Strategy Related To Hedge Accounting [Line Items]  
Summary of Judgments of Reasonably Possible Movements

At June 30, 2025, 2024 and 2023, if interest rates moved, with all variables held constant, post tax (loss)/profit and equity would have been affected as illustrated in the following table:

 

 

Post tax (loss)/profit impact

 

 

 

2025

 

 

2024

 

 

2023

 

 

US$(000's)

 

 

US$(000's)

 

 

US$(000's)

 

Judgments of reasonably possible movements

 

 

 

 

 

 

 

+0.50% (50 basis points) (2024:+0.50%, 2023:+0.50%)

 

 

120

 

 

 

283

 

 

 

270

 

-0.50% (50 basis points) (2024:-0.50%, 2023:-0.50%)

 

 

(120

)

 

 

(283

)

 

 

(270

)

Currency Risk  
Disclosure Of Risk Management Strategy Related To Hedge Accounting [Line Items]  
Summary of Judgments of Reasonably Possible Movements

At June 30, 2025, 2024 and 2023, had the United States dollar moved with all other variables held constant, post-tax (loss) profit and equity would have been affected as illustrated in the table below:

 

 

 

Post tax (loss)/profit impact

 

 

 

2025

 

 

2024

 

 

2023

 

 

US$(000's)

 

 

US$(000's)

 

 

US$(000's)

 

Judgments of reasonably possible movements

 

 

 

 

 

 

 

Consolidated

 

 

 

 

 

 

 

 

 

AUD/USD +10% (2024:+10%, 2023:+10%)

 

 

(299

)

 

 

(9,006

)

 

 

(3,847

)

AUD/USD -10% (2024:-10%, 2023:-10%)

 

 

365

 

 

 

11,007

 

 

 

4,702

 

Summary of Exposure to Foreign Currency Risk

At the reporting date, the Group has the following exposure to foreign currencies. :

 

 

 

Consolidated

 

 

 

AUD

 

 

EURO

 

 

GBP

 

 

CAD

 

2025

 

US$(000's)

 

 

US$(000's)

 

 

US$(000's)

 

 

US$(000's)

 

Financial assets

 

 

 

 

 

 

 

 

 

 

 

 

Cash

 

 

7,581

 

 

 

 

 

 

 

 

 

 

Receivables

 

 

26

 

 

 

 

 

 

 

 

 

 

Financial liabilities

 

 

 

 

 

 

 

 

 

 

 

 

Payables

 

 

(3,225

)

 

 

 

 

 

(6

)

 

 

(5

)

Other financial liabilities

 

 

 

 

 

 

 

 

 

 

 

 

Net exposure

 

 

4,382

 

 

 

 

 

 

(6

)

 

 

(5

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Consolidated

 

 

 

AUD

 

 

EURO

 

 

GBP

 

 

CAD

 

2024

 

US$(000's)

 

 

US$(000's)

 

 

US$(000's)

 

 

US$(000's)

 

Financial assets

 

 

 

 

 

 

 

 

 

 

 

 

Cash

 

 

131,914

 

 

 

 

 

 

 

 

 

 

Receivables

 

 

486

 

 

 

 

 

 

 

 

 

 

Financial liabilities

 

 

 

 

 

 

 

 

 

 

 

 

Payables

 

 

(2,350

)

 

 

(488

)

 

 

(3

)

 

 

(13

)

Other financial liabilities

 

 

 

 

 

 

 

 

 

 

 

 

Net exposure

 

 

130,050

 

 

 

(488

)

 

 

(3

)

 

 

(13

)

Liquidity Risk  
Disclosure Of Risk Management Strategy Related To Hedge Accounting [Line Items]  
Summary of Undiscounted Cash Flows of the Financial Liabilities

The table below reflects undiscounted cash flows of the financial liabilities.

 

 

 

Consolidated

 

 

 

 

 

 

Carrying
amount

 

 

Less than 3
months

 

 

Between 3
months and
1 year

 

 

1 year and
later

 

 

Total

 

 

 

US$(000's)

 

 

US$(000's)

 

 

US$(000's)

 

 

US$(000's)

 

 

US$(000's)

 

June 30, 2025

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Non-derivative liabilities

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Payables

 

 

2,917

 

 

 

2,917

 

 

 

-

 

 

 

-

 

 

 

2,917

 

Accrued expenses

 

 

6,819

 

 

 

6,819

 

 

 

-

 

 

 

-

 

 

 

6,819

 

Financial liability - DFA1

 

 

246,993

 

 

 

-

 

 

 

246,993

 

 

 

-

 

 

 

246,993

 

Total

 

 

256,729

 

 

 

9,736

 

 

 

246,993

 

 

 

-

 

 

 

256,729

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Consolidated

 

 

 

 

 

 

Carrying
amount

 

 

Less than 3
months

 

 

Between 3
months and
1 year

 

 

1 year and
later

 

 

Total

 

 

 

US$(000's)

 

 

US$(000's)

 

 

US$(000's)

 

 

US$(000's)

 

 

US$(000's)

 

June 30, 2024

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Non-derivative liabilities

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Payables

 

 

9,472

 

 

 

9,472

 

 

 

-

 

 

 

-

 

 

 

9,472

 

Accrued expenses

 

 

28,483

 

 

 

27,279

 

 

 

1,204

 

 

 

-

 

 

 

28,483

 

Financial liability - DFA

 

 

200,536

 

 

 

-

 

 

 

-

 

 

 

731,000

 

 

 

731,000

 

Total

 

 

238,491

 

 

 

36,751

 

 

 

1,204

 

 

 

731,000

 

 

 

768,955

 

 

1. Following the termination of the clinical trials, the Group did not have a right to defer settlement of the liability for at least twelve months after the reporting period and therefore the liability is reflected in the period between 3 months and 1 year. Refer to Note 27.